Trial Profile
Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jan 2022
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 28 Jun 2021 Results published in the Clinical Transplantation
- 16 Jul 2020 Status changed from active, no longer recruiting to completed.
- 09 Mar 2020 Planned primary completion date changed from 28 Feb 2020 to 1 May 2020.